A preview of this full-text is provided by SAGE Publications Inc.
Content available from Natural Product Communications
This content is subject to copyright.
Bioactive Constituents from Michelia champaca
Yu-Ting Yeha, Jin-Cherng Huangb, Po-Lin Kuoc,* and Chung-Yi Chena,*
aSchool of Medical and Health Sciences, Fooyin University, Kaohsiung 831, Taiwan, R.O.C.
bDepartment of Forest Products Science and Furniture Engineering, National Chiayi University,
Chiayi 600, Taiwan, R.O.C.
cInstitute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.
xx377@mail.fy.edu.tw; kuopolin@seed.net.tw
Received: June 1st, 2011; Accepted: June 11th, 2011
(-)-Anonaine (1), (-)-asimilobine (2), (-)-nuciferine (3), (-)-anolobine (4), (-)-romerine (5), (-)-N-acetylanonaine (6), liriodenine (7),
(+)-syringaresinol (8), N-trans-feruloyltyramine (9), N-cis-feruloyltyramine (10), scopoletin (11), 4-acetonyl-3,5-dimethoxy-p-quinol (12),
vanillin (13), vanillic acid (14), syringic acid (15), -sitosterol (16) and stigmasterol (17) were isolated from branches of Michelia champaca
L. In addition, a cell proliferation assay of five of the isolated compounds on human breast and lung cancer cells showed that liriodenine (7)
was the strongest inhibitor.
Keywords: Michelia champaca L., aporphine, liriodenine.
Breast cancer is the most common female cancer,
comprising 23% of all cancers, with more than 1 million
new cases per year. Effective chemopreventive treatments
for breast cancer are still needed to increase available
regimens and advance the efficacy of chemotherapy
[1a-1c]. Lung cancer is one of the most common malignant
and devastating of human tumors. Non-small cell lung
cancer (NSCLC) A549 cells commonly develop resistance
to radiation and chemotherapy [1d,1e]. Nevertheless, a
great number of tumor histotypes show a low or very low
response to such treatment, and only some display optimal
results after its application. This is the main reason that the
search for new anticancer compounds that are more
effective against unresponsive tumors, with reduced
adverse effects, is considered an important step in
improving cancer chemotherapy [1f,1g].
Michelia champaca L. is a large evergreen tree, native to
South and Southeast Asia, which is primarily cultivated for
its timber; its aril-covered seeds are highly attractive to
birds [2a]. Previous phytochemical studies led to the
isolation of ushinsunine, oxoushinsunine, magnoflorine,
parthenolide, costunolide, dihydroparthenolide, micheli-
nolide, 11,13-dehydrolanuginolide, magnograndiolide,
michampanolide, quercetin, benzaldehyde 4-O-β-D-gluco-
pyranoside, syringaresinol, and N-acetylanonaine [2b-2f].
To continue the search for novel agents from Magnoliaceous
plants, the branches of M. champaca were chosen for the
first time for phytochemical investigation. In this paper,
we report the isolation of seventeen compounds, including
six aporphines: (-)-anonaine (1) [2g], (-)-asimilobine (2)
[2h], (-)-nuciferine (3) [2i], (-)-anolobine (4) [2j], (-)-
romerine (5) [2h], and (-)-N-acetylanonaine (6) [2h]; one
N
O
O
R
H
5: R = CH3
6: R = COCH3
N
O
O
O
7
N
O
H
HO
H3CO
OH
9
0
20
40
60
80
100
120
Control
Liriodenine
Vanillin
(-)-Roemerine
(-)-N-Acety lanonaine
N-trans-Feruloyltyrami ne
Cell proliferation (% of control)
A
549
*
***
0
20
40
60
80
100
120
Control
Liriodenine
Vanillin
(-)-Roemerine
(-)-N-Acetylanonaine
N-trans-Ferulo yltyramine
Cell proliferation ( % of control)
MDA-MB-231
**
*
*
Figure 1: Antiproliferative effect of liriodenine, vanillin, (-)-roemerine, (-)-N-
acetylanonaine, and N-trans-feruloyltyramine on A549 cells and MDA-MB-231 cells.
oxoaporphine: liriodenine (7) [2k]; one lignan: (+)-
syringaresinol (8) [2e]; one amide: N-trans-
feruloyltyramine (9) [2l], N-cis-feruloyltyramine (10) [2l];
one coumarin: scopoletin (11) [2m]; one quinol: 4-
acetonyl-3,5-dimethoxy-p-quinol (12) [2n]; three
benzenoids: vanillin (13) [2o], vanillic acid (14) [2g], and
syringic acid (15) [2p]; and two steroids: -sitosterol (16)
[2q] and stigmasterol (18) [2h]. All compounds, except 6
and 8, are found for the first time from this plant [2b-2f].
To evaluate the relative anticancer activity of liriodenine,
vanillin, (-)-roemerine, (-)-N-acetylanonaine, and N-trans-
feruloyltyramine, we investigated their proliferation
inhibition effects in A549 human lung adenocarcinoma
cells and MDA-MB-231 human breast adenocarcinoma
cells. As shown in Figure 1, the maximal effect on
proliferation inhibition was observed with 20 µM
liriodenine at 48 h, which inhibited proliferation of
A549 and MDA-MB-231 cells by 54.4% and 51.7%,
NPC Natural Product Communications 2011
Vol. 6
No. 9
1251 - 1252
1252 Natural Product Communications Vol. 6 (9) 2011 Cheng et al.
respectively. In contrast, 20 µM (-)-N-acetylanonaine at 48
h did not affect cell viability of A549 and MDA-MB-231
cells.
Experimental
Cell culture and cell proliferation assay: A549 human
lung adenocarcinoma cells and MDA-MB-231 human
breast adenocarcinoma cells were cultured in Minimum
essential medium supplemented with 10% FBS, 100 units/
mL of penicillin G, 100 µg/mL of streptomycin, and 0.25
µg/mL of amphotericin B (GIBCO BRL, Gaithersburg,
MD, USA). All test compounds were dissolved in DMSO
and stored at -20°C. Control cultures received the carrier
solvent (0.1% DMSO). Cell proliferation was assessed by
Premixed WST-1 Cell Proliferation Reagent (Clontech
Laboratories Inc., Mountain View, CA, USA) according to
the manufacturer’s instructions.
Purification of active ingredients from M. champaca:
Michelia champaca L. was collected from Pingtung
County, Taiwan in December, 2009. A voucher specimen
was characterized by Dr Jin-Cherng Huang of the National
Chiayi University, and deposited in Fooyin University,
Kaohsiung County, Taiwan.
The air-dried branches of M. champaca (11.0 kg) were
extracted with MeOH (80 L x 6) at room temperature and
the MeOH extract (181.5 g) obtained after concentration
under reduced pressure. This was chromatographed over
silica gel (800 g, 70-230 mesh) using n-hexane/acetone as
eluent to produce 5 fractions. These (supporting material)
were subjected to repeated Si gel CC and preparative
TLC to afford β-sitosterol (10.41 mg) and stigmasterol
(6.67 mg) from fraction 1, liriodenine (12.53 mg), (-)-N-
acetyl- anonaine (6.01 mg), scopoletin (4.42 mg), (+)-
syringaresinol (5.62 mg) and vanillin (4.35 mg) from
fraction 2, vanillic acid (4.26 mg) from fraction 3,4-
acetonyl-3,5-dimethoxy-p-quinol (12.54 mg), syringic acid
(15.03 mg), N-trans-feruloyltyramine (5.36 mg), N-cis-
feruloyltyramine (2.25 mg), and (-)-romerine (8.47 mg)
from fraction 4, and (-)-anonaine (9.02 mg), (-)-
asimilobine (11.08 mg), (-)-nuciferine (6.71 mg) and (-)-
anolobine (5.37 mg) from fraction 5.
Supporting data: Detailed isolation procedure.
Acknowledgments - This investigation was supported by
a grant from the National Science Council of the Republic
of China (NSC 97-2320-B-242-002-MY3).
References
[1] (a) Baselga J, Mendelsohn J. (1994) The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast
Cancer Research Treatment, 29, 127-138; (b) Bange J, Zwick E, Ullrich A. (2001) Molecular targets for breast cancer therapy and
prevention. Nature Medicine, 7, 548-552; (c) Roy AM, Baliga MS, Katiyar SK. (2005) Epigallocatechin-3-gallate induces
apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and
caspase-3 activation. Molecular Cancer Therapeutics, 4, 81-90; (d) Cordes N, Beinke C, Plasswilm L, van Beuningen D. (2004)
Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and ß1-integrin clustering in human A549 lung cancer
cells in a substratum-dependent manner in vitro. Strahlenther Onkol, 180, 157-164; (e) Kim PK, Park SY, Koty PP, Hua Y,
Luketich JD, Billiar TR. (2003) Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells.
Journal of Thoracic and Cardiovascular Surgery, 125, 1336-1342; (f) Peters GJ, Smorenburg CH, Van Groeningen CJ. (2004)
Prospective clinical trials using a pharmacogenetic /pharmacogenomic approach. Journal of Chemotherapy (Florence, Italy), 16,
25-30; (g) Kurbacher CM, Mallmann PK. (1998) Chemoprotection in anticancer therapy: the emerging role of amifostine.
Anticancer Research, 18, 2203-2210.
[2] (a) Frisch JD, Frisch CD. (2005) Aves Brasileiras e Plantas que as atraem, 3rd, 374; (b) Yang TH, Hsiao CY. (1963) Studies on the
alkaloids of Magnoliaceous plants. XXXVI. Alkaloids of Michelia champaca Linn. The Journal of Pharmacy, 83, 216-221; (c)
Sethi VK, Thappa RK, Dhar KL, Atal CK. (1984) Constituents of Michelia champaca and Lewis acid catalyzed transformations of
parthenolide into guaianolides. Planta Medica, 50, 364-367; (d) Jacobsson U, Kumar V, Saminathan S. (1995) Sesquiterpene
lactones from Michelia champaca. Phytochemistry, 39, 839-843; (e) Kapoor S, Jaggi RK. (2004) Chemical studies on flowers of
Michelia champaca. Indian Journal of Pharmaceutical Sciences, 66, 403-406; (f) Monteiro MCM, Leptokarydis IH, Silva GH, da
Silva VC, Bolzani VS, Young MCM, Lopes MN. (2007) Chemical constituents of stems from Michelia champaca L.
(Magnoliaceae). Ecletica Quimica, 32, 13-17; (g) Lo WL, Wu YC, Hsieh TY, Kuo SH. (2004) Chemical constituents from the
stems of Michelia compressa, Chinese Pharmaceutical Journal, 56, 69-75; (h) Chen CY, Huang LY, Chen LJ, Lo WL, Kuo SY,
Wang YD, Kuo SH, Hsieh TJ. (2008) Chemical constituents from the leaves of Michelia alba. Chemistry of Natural Compounds,
44, 137-139; (i) Yang TH, Chen CM, Lu CS, Liao CL. (1972) Studies on the alkaloids of lotus receptacle. Journal of the Chinese
Chemical Society, 19, 143-147; (j) Yang TH, Chen CM. (1970) Studies on the constituents of Annona squamosa L., Journal of the
Chinese Chemical Society, 17, 243-250; (k) Talapatra SK, Patra A, Talapatra B, (1975) Alkaloids of Micheila lanuginosa Wall.
Tetrahedron, 31, 1105-1107; (l) Liu CY, Chen YW, Cheng MJ, Lee SJ, Chang WH, Chen YJ, Chen IS. (2008) Cytotoxic
constituents from the root wood of Formosan Michelia compressa. Journal of the Chinese Chemical Society, 53, 1523-1524; (m)
Ceaspedes CL, Avila, JG, Martinez A, Serrato B, Calderon-Mugica JC, Salgado-Garciglia R. (2006) Antifungal and antibacterial
activities of Mexican tarragon (Tagetes lucida). Journal of Agricultural and Food Chemistry, 54, 3521-3527; (n) Luo JR, Jiang HE,
Zhao YX, Zhao J. (2008) Components of the heartwood of Populus enphratica from an ancient tomb. Chemistry of Natural
Compounds, 44, 6-9; (o) Kuo SY, Hsieh TJ, Wang YD, Lo WL, Hsui YR, Chen CY. (2008) Cytotoxic constituents from the leaves
of Cinnamomum subavenium. Chemical & Pharmaceutical Bulletin, 56, 97-101; (p) Chen CY, Chang FR, Teng CM, Wu YC.
(1999) Cheritamine, a new N-fatty acyl tryptamine and other constituents from the stems of Annona cherimola. Journal of the
Chinese Chemical Society, 46, 77-86; (q) Likhitwitayawuid K, Ruangrungsi N, Borboon M, Lange GL, Decicco CP. (1988) Studies
on Thai medicinal plants. Part VII. Constituents of the stem bark of Michelia longifolia, Journal of the Science Society of Thailand,
14, 73-76.
Content uploaded by Chung-Yi Chen
Author content
All content in this area was uploaded by Chung-Yi Chen on Oct 15, 2014
Content may be subject to copyright.